Table 1. Good prognostic genes for patients of the HM cohort.
Probe set | Name | Beta Coefficient | HR | P value |
---|---|---|---|---|
202449_s_at | RXRA | −0.36 | 0.7 | 0.0011 |
210515_at | HNF1A | −0.29 | 0.75 | 0.0082 |
220331_at | CYP46A1 | −0.28 | 0.75 | 0.0086 |
203455_s_at | SAT1 | −0.26 | 0.77 | 0.013 |
201250_s_at | SLC2A1 | −0.25 | 0.78 | 0.016 |
202436_s_at | CYP1B1 | −0.3 | 0.74 | 0.024 |
206913_at | BAAT | −0.23 | 0.79 | 0.025 |
202499_s_at | SLC2A3 | −0.33 | 0.72 | 0.028 |
228497_at | SLC22A15 | −0.24 | 0.79 | 0.033 |
205322_s_at | MTF1 | −0.23 | 0.79 | 0.034 |
206340_at | NR1H4 | −0.22 | 0.81 | 0.037 |
203814_s_at | NQO2 | −0.24 | 0.79 | 0.038 |
205896_at | SLC22A4 | −0.27 | 0.76 | 0.042 |
210301_at | XDH | −0.19 | 0.82 | 0.049 |